Study finds coronavirus vector vaccine compared to mRNA to prevent serious illnesses and deaths but need to boost dose

Facebook
Twitter
LinkedIn
Pinterest
Pocket
WhatsApp
Research shows that the efficacy of the coronavirus vector vaccine is as effective as mRNA in extracting serious illnesses and deaths. but need to boost dose

On April 27, at the Renaissance Bangkok Ratchaprasong Hotel, Southeast Asian Ministers of Education Organization (SEAMEO), the regional network for tropical medicine and public health, or SEMI OTHERMED in Thailand and the College of Physicians of the Philippines. make a reportThe effectiveness of the COVID-19 vaccine through the online format on the platform Zoom (zoom)

Mr. Ron Jean Solante College of Physicians of the Philippines has reported a new data analysis by experts from research from more than 79 case studies that the vaccine prevents COVID-19 that is widely used all over the world They were equally effective in preventing hospitalizations (hospitals) and deaths from COVID-19. After 2 doses of vaccination

Mr Ron China said. The report clearly shows information that both AstraZeneca’s COVID-19 vaccine The viral vector vaccine and the mRNA vaccine against COVID-19 were both effective in preventing hospital admissions, with Astra at 92.5 percent, and mRNA at 91.3 percent and preventing hospitalization. Mortality in Astra was 91.4 percent and mRNA was 93.3 percent, with no statistically significant difference. It covers patients of all ages. But data from a new wave of outbreaks It indicates a similar effect on the effectiveness of vaccines in preventing severe symptoms of COVID-19. Omicron species

on the side Dr. Sunet Chuenkitmongkol, MD. The deputy director of the National Institute of Vaccines said research should take into account a combination of factors. This will have to look at the effectiveness of the vaccine from real case studies. In Thailand, experiments were conducted from four regions in four provinces, namely Chiang Mai, Kalasin, Bangkok and Phuket, which found that the results were consistent with both viral vectors and mRNA, with the rate of protection against entry. hospital and died well ensuring that the population of Thailand is well protected

Read Also  Covid today, Chonburi. 170 more infected. Cluster of conscripts still out of control.

The reporter asked to enter into an endemic disease Although at the moment the third injection is 36 percent of the whole country. How many injections will be needed to be enough? Dr. Sunet said No one could answer that. How many injections will be enough? But today we can clearly see that High-risk vulnerable groups Must get as many booster pins as possible. The percentage that can be compared Maybe look at the time of the epidemic of the Delta species. We vaccinate 70% of the population. and saw that the rate of violence had clearly subsided

Assoc.Prof.Dr. Pratap Singhasiwanon, MD. The secretary-general of SEMEOTROMED network said he had seen the benefits of vaccination. and after injection over time The efficacy in preventing the severity of the disease is lower, so two doses of vaccine are not enough. The injection of a stimulating needle (booster dose) or a third needle will increase the effectiveness of prevention. Regardless of whether the vaccine is viral, vector or mRNA, it is imperative to encourage people to have access to the vaccine as much as possible. to reduce the burden of hospital beds or prevent death

side Mr Bruce Mungall Regional Medical Director for Asia Vaccines and Infectious Diseases AstraZeneca Singapore said the data showed How effective are the different brands of vaccines? This allows them to have options for vaccination. They also understand and can choose the one that is right for themselves.

Facebook
Twitter
LinkedIn
Pinterest
Pocket
WhatsApp

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Recent News

Editor's Pick